Over Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
HoofdkantoorCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Opgericht2013
StatusActief
Octrooien60 octrooien
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Log in om alle 60 octrooien te zien
Bekijk de volledige octrooiportefeuille, met publicatienummers, datums en families.
Aanmelden Maak een account aan met uw e-mailadresHet is gratis
Door verder te gaan, gaat u akkoord met de Gebruikersovereenkomst, het Privacybeleid en het Cookiebeleid van Heelky.
Beoordelingen
Nog geen beoordelingen. Met Onyx Pharmaceuticals, Inc. gewerkt? Wees de eerste die je ervaring deelt.
Juridische informatie
| Wettelijke naam | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Bekijken op GLEIF ↗ |
| Vestigingsadres | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Status | Actief |
Bronnen: GLEIF · bijgewerkt 16 oktober 2026
Contact en links
Locatie
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Is dit jouw bedrijf?
Claim deze pagina gratis om je logo, producten, foto’s en vacatures toe te voegen, en om op beoordelingen te antwoorden.
Deze pagina claimenWord lid van Heelky om te verbinden, in te huren en te groeien
Maak een gratis account om mensen een bericht te sturen, te solliciteren en opdrachten te plaatsen.
Nu meedoen — het is gratis